| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.TAAP.2006.03.010 |
| P698 | PubMed publication ID | 16712894 |
| P50 | author | Michael P. Waalkes | Q113460555 |
| P2093 | author name string | Jie Liu | |
| Jerrold M Ward | |||
| Bhalchandra A Diwan | |||
| P433 | issue | 3 | |
| P921 | main subject | arsenic | Q871 |
| carcinogenesis | Q1637543 | ||
| tamoxifen | Q412178 | ||
| P304 | page(s) | 295-305 | |
| P577 | publication date | 2006-05-18 | |
| P1433 | published in | Toxicology and Applied Pharmacology | Q2446974 |
| P1476 | title | Enhanced urinary bladder and liver carcinogenesis in male CD1 mice exposed to transplacental inorganic arsenic and postnatal diethylstilbestrol or tamoxifen. | |
| P478 | volume | 215 |
| Q36768351 | Aberrant DNA methylation and gene expression in livers of newborn mice transplacentally exposed to a hepatocarcinogenic dose of inorganic arsenic |
| Q42498074 | Acetaminophen increases the risk of arsenic-mediated development of hepatic damage in rats by enhancing redox-signaling mechanism |
| Q28387404 | Arsenic and cardiovascular disease |
| Q43071433 | Arsenic exposure in utero and nonepidermal proliferative response in adulthood in Tg.AC mice |
| Q34593837 | Arsenic, Stem Cells, and the Developmental Basis of Adult Cancer |
| Q37231348 | Arsenic-induced aberrant gene expression in fetal mouse primary liver-cell cultures |
| Q28387869 | Cancer in experimental animals exposed to arsenic and arsenic compounds |
| Q24707869 | Carcinogenic Effects of “Whole-Life” Exposure to Inorganic Arsenic in CD1 Mice |
| Q35597576 | Chronic subhepatotoxic exposure to arsenic enhances hepatic injury caused by high fat diet in mice. |
| Q91650177 | Concordance between sites of tumor development in humans and in experimental animals for 111 agents that are carcinogenic to humans |
| Q28396890 | Determinants of arsenic metabolism: blood arsenic metabolites, plasma folate, cobalamin, and homocysteine concentrations in maternal-newborn pairs |
| Q64954377 | Diethylnitrosamine (DENA) recapitulates formation of hepatic angiosarcoma in pigs. |
| Q34180578 | Early life inorganic lead exposure induces testicular teratoma and renal and urinary bladder preneoplasia in adult metallothionein-knockout mice but not in wild type mice |
| Q34138716 | Environmental toxicants and the developing immune system: a missing link in the global battle against infectious disease? |
| Q34371580 | Evaluation of the carcinogenicity of inorganic arsenic |
| Q33964023 | Exposure to multiple metals from groundwater-a global crisis: geology, climate change, health effects, testing, and mitigation |
| Q43295840 | Fetal arsenic exposure appears to facilitate endocrine disruption by postnatal diethylstilbestrol in neonatal mouse adrenal |
| Q28389068 | Fetal onset of aberrant gene expression relevant to pulmonary carcinogenesis in lung adenocarcinoma development induced by in utero arsenic exposure |
| Q37942796 | Genetic and epigenetic effects of environmental arsenicals |
| Q28389104 | In utero and early life arsenic exposure in relation to long-term health and disease |
| Q26799414 | In utero arsenic exposure in mice and early life susceptibility to cancer |
| Q35164353 | Involvement of epigenetics and EMT-related miRNA in arsenic-induced neoplastic transformation and their potential clinical use. |
| Q28390690 | Liver is a target of arsenic carcinogenesis |
| Q24707867 | Lung tumors in mice induced by "whole-life" inorganic arsenic exposure at human-relevant doses |
| Q36567337 | Mechanisms Underlying Latent Disease Risk Associated with Early-Life Arsenic Exposure: Current Research Trends and Scientific Gaps. |
| Q37398906 | Oral exposure to inorganic arsenic: evaluation of its carcinogenic and non-carcinogenic effects |
| Q28395923 | Pharmacokinetic and Genomic Effects of Arsenite in Drinking Water on Mouse Lung in a 30-Day Exposure |
| Q53245627 | Pigmented well-differentiated hepatocellular neoplasm with beta-catenin mutation. |
| Q33575070 | Predicting environmental chemical factors associated with disease-related gene expression data |
| Q89597887 | Prostate Cancer Incidence in U.S. Counties and Low Levels of Arsenic in Drinking Water |
| Q24707868 | Renal, hepatic, pulmonary and adrenal tumors induced by prenatal inorganic arsenic followed by dimethylarsinic acid in adulthood in CD1 mice |
| Q43013035 | Response to letter to the editor by Cohen et al. (2014) "Re: Waalkes et al.: Lung tumors in mice induced by "whole-life" inorganic arsenic exposure at human-relevant doses, Arch Toxicol, 2014". |
| Q38099200 | Role of oestrogen receptors in bladder cancer development |
| Q37302943 | Role of sex steroid receptors in pathobiology of hepatocellular carcinoma |
| Q36464940 | Subhepatotoxic exposure to arsenic enhances lipopolysaccharide-induced liver injury in mice |
| Q36339038 | The epigenetic effects of a high prenatal folate intake in male mouse fetuses exposed in utero to arsenic |
| Q53295265 | The impact of recent advances in research on arsenic cancer risk assessment. |
| Q36929584 | The steroidogenic acute regulatory protein as a target of endocrine disruption in male reproduction |
| Q27687049 | Toxicant-associated steatohepatitis |
| Q28396711 | Transplacental arsenic carcinogenesis in mice |
| Q37187687 | Transplacental exposure to inorganic arsenic at a hepatocarcinogenic dose induces fetal gene expression changes in mice indicative of aberrant estrogen signaling and disrupted steroid metabolism |
| Q36281917 | Tumors and proliferative lesions in adult offspring after maternal exposure to methylarsonous acid during gestation in CD1 mice |
Search more.